Evidence map›Paper›PMID 40261554›Full record

ArticleCVIR endovascular2025

Micro-CT and histological assessment of renal arterial embolization with Glubran®2 cyanoacrylate: a medium-term follow-up study in a rabbit model.

Romaric Loffroy, Kévin Guillen, Olivier Chevallier, Mohamed Fouad, Emilie Couloumy, Anne Dencausse, Philippe Robert, Sarah Catoen, Anne-Virginie Salsac, Serge Ludwig Aho-Glele and 1 more

Abstract read
In one paragraph

Article in CVIR endovascular, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Romaric LoffroyDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, 21079, France. romaric.loffroy@chu-dijon.fr.ORCID http://orcid.org/0000-0002-3107-5967
Kévin GuillenDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, 21079, France.
Olivier ChevallierDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, 21079, France.
Mohamed FouadDepartment of Vascular and Interventional Radiology, Image-Guided Therapy Center, François-Mitterrand University Hospital, Dijon, 21079, France.
Emilie CouloumyR&D, Guerbet Research, Roissy Charles-de-Gaulle, 95943, France.
Anne DencausseR&D, Guerbet Research, Roissy Charles-de-Gaulle, 95943, France.
Philippe RobertR&D, Guerbet Research, Roissy Charles-de-Gaulle, 95943, France.
Sarah CatoenR&D, Guerbet Research, Roissy Charles-de-Gaulle, 95943, France.
Anne-Virginie SalsacBiomechanics and Bioengineering Laboratory, UMR CNRS 7338, Université de Technologie de Compiègne, Compiègne, 60203, France.
Serge Ludwig Aho-GleleDepartment of Epidemiology, Statistics and Clinical Research, François-Mitterrand University Hospital, Dijon, 21079, France.
Pierre-Olivier CombyICMUB Laboratory, UMR CNRS 6302, Université de Bourgogne, Dijon, 210000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCyanoacrylate glues are widely used in interventional radiology as effective embolic agents due to their rapid polymerization and ability to achieve vessel occlusion. Nonetheless, concern remains regarding cast stability and potential recanalization over time. This study used multiple modalities to evaluate the medium-term outcomes of Glubran®2 glue (methacryloxysulfolane and N butyl cyanoacrylate) embolisation in a rabbit renal-artery model.

methodsThe left renal arteries of six rabbits were embolized with 12.5% or 25% Glubran®2. In-vivo micro-CT scans were performed immediately after embolisation (M0) and ex-vivo scans and a histological assessment were done at one month (M1). Magnetic resonance imaging (MRI) was done at M1 to assess arterial occlusion and parenchymal changes. Quantitative and semi-quantitative parameters reflecting glue distribution, cast integrity, and tissue response were analysed. Statistical comparisons used non-parametric tests.

resultsAll six embolisations were completed without complications. Micro-CT at M1 revealed significant cast resorption and fragmentation with both concentrations, but with no evidence of arterial recanalization. MRI and histology confirmed the persistent vascular occlusion with chronic ischemic changes in the renal parenchyma. Compensatory neovascularization from the renal capsule was observed, with no significant differences in histological inflammation between the two concentrations. Glue casts remained within the arterial lumens and were often surrounded by granulomatous inflammation.

conclusionsGlubran®2 was effective for renal artery embolisation, even at a low concentration of 12.5%: despite partial cast resorption, the arteries remained occluded. Micro-CT proved to be a powerful tool for assessing changes in glue casts. Longer-term studies are warranted to further assess vascular remodelling and occlusion durability.

Indexed as

Animal modelMedium-term outcomesN-butyl cyanoacrylate glueTranscatheter arterial embolization

Identifiers

PMID40261554
PMCPMC12014886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.